Panion & Bf Biotech Balance Sheet Health
Financial Health criteria checks 5/6
Panion & Bf Biotech has a total shareholder equity of NT$1.9B and total debt of NT$725.6M, which brings its debt-to-equity ratio to 39.1%. Its total assets and total liabilities are NT$3.3B and NT$1.4B respectively. Panion & Bf Biotech's EBIT is NT$193.4M making its interest coverage ratio 207. It has cash and short-term investments of NT$581.9M.
Key information
39.1%
Debt to equity ratio
NT$725.56m
Debt
| Interest coverage ratio | 207x |
| Cash | NT$581.86m |
| Equity | NT$1.85b |
| Total liabilities | NT$1.40b |
| Total assets | NT$3.25b |
Recent financial health updates
Is Panion & Bf Biotech (TWSE:1760) A Risky Investment?
Aug 13
Here's Why Panion & Bf Biotech (TPE:1760) Has A Meaningful Debt Burden
Apr 07Panion & Bf Biotech (TPE:1760) Has A Somewhat Strained Balance Sheet
Dec 14
Recent updates
Is Panion & Bf Biotech (TWSE:1760) A Risky Investment?
Aug 13Here's Why Panion & Bf Biotech (TPE:1760) Has A Meaningful Debt Burden
Apr 07Is Panion & Bf Biotech Inc. (TPE:1760) A Strong Dividend Stock?
Mar 03Introducing Panion & Bf Biotech (TPE:1760), A Stock That Climbed 47% In The Last Three Years
Feb 04Are Panion & Bf Biotech Inc.'s (TPE:1760) Mixed Financials Driving The Negative Sentiment?
Jan 09Panion & Bf Biotech (TPE:1760) Has A Somewhat Strained Balance Sheet
Dec 14Financial Position Analysis
Short Term Liabilities: 1760's short term assets (NT$1.5B) exceed its short term liabilities (NT$1.1B).
Long Term Liabilities: 1760's short term assets (NT$1.5B) exceed its long term liabilities (NT$272.0M).
Debt to Equity History and Analysis
Debt Level: 1760's net debt to equity ratio (7.8%) is considered satisfactory.
Reducing Debt: 1760's debt to equity ratio has increased from 0% to 39.1% over the past 5 years.
Debt Coverage: 1760's debt is well covered by operating cash flow (40.7%).
Interest Coverage: 1760's interest payments on its debt are well covered by EBIT (207x coverage).